JAX Tech Talk Episode 51: Let’s Talk Accelerating Research with JAX’s GvHD Platform (Mar. 1, 2022)
March 1, 2022 - In addition to providing researchers with genetically stable, high health status NSG™ mice and study-ready hu-PBMC mice, The Jackson Laboratory also helps design and execute studies to evaluate the efficacy of drugs to treat GvHD. In this episode, the JAX Tech Talk Team welcomes Prabir Banerjee to discuss the JAX GvHD platform and its value in accelerating your preclinical research studies. Join us to learn about the unique benefits of JAX’s GvHD platform and have your questions answered LIVE by our experts.
Graft versus Host Disease (GvHD) Efficacy Studies
GvHD Efficacy Study Fact Sheet
Blog Post: Investigating Immunomodulation: Examining GvHD Using Humanized NSG™ from JAX Mice